Heparan Sulfate Analog SPGG- a Potent Inhibitor of Human Cytomegalovirus Infection.

被引：0
|
作者：
Kaltenbach, Dominik D. [1 ,2 ,3 ]
Elste, James [2 ]
Sharthiya, Harsh [3 ]
Fornaro, Michele [3 ]
Desai, Umesh R. [4 ,5 ]
Tiwari, Vaibhav [2 ]
机构：
[1] Midwestern Univ, Dept Biomed Sci, Downers Grove, IL 60515 USA
[2] Midwestern Univ, Dept Microbiol & Immunol, Downers Grove, IL 60515 USA
[3] Midwestern Univ, Dept Anat, Downers Grove, IL 60515 USA
[4] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA
[5] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23219 USA
来源：
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL | 2019年 / 55卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A-3005
引用
收藏
页码：571 / 572
页数：2
相关论文
共 50 条
  • [1] Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry
    Murray, M. J.
    Bonilla-Medrano, N., I
    Lee, Q. L.
    Oxenford, S. J.
    Angell, R.
    Depledge, D. P.
    Reeves, M. B.
    JOURNAL OF VIROLOGY, 2020, 94 (07)
  • [2] Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus Infection In Vitro and In Vivo
    Young, Jesse M.
    El Abidine, Amira Zine
    Gomez-Martinez, Ricardo A.
    Bondu, Virginie
    Sterk, Rosa T.
    Surviladze, Zurab
    Ozbun, Michelle A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (01)
  • [3] HEPARAN-SULFATE IS A POTENT INHIBITOR OF DNA-SYNTHESIS INVITRO
    WINTERBOURNE, DJ
    SALISBURY, JG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (01) : 30 - 37
  • [4] A Role for 3-O-Sulfated Heparan Sulfate in Promoting Human Cytomegalovirus Infection in Human Iris Cells
    Baldwin, John
    Maus, Erika
    Zanotti, Brian
    Volin, Michael V.
    Tandon, Ritesh
    Shukla, Deepak
    Tiwari, Vaibhav
    JOURNAL OF VIROLOGY, 2015, 89 (09) : 5185 - 5192
  • [5] Novel role for galectin-9 as a potent inhibitor of human cytomegalovirus infection
    Machala, E. A.
    McSharry, B. P.
    Abendroth, A.
    Slobedman, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 679 - 679
  • [6] Characteristics of Fas ligand expression by human cytomegalovirus infection.
    Hwnag, ES
    Kim, JH
    Kwon, YJ
    Jung, HJ
    Kim, SY
    Park, CG
    Cha, CY
    CLINICAL IMMUNOLOGY, 2005, 115 : S164 - S164
  • [7] Human cytomegalovirus induces the suppression of hematopoiesis by direct infection.
    He, ZX
    Chen, JL
    Xiong, W
    Li, K
    Wang, QW
    Deng, HZ
    Pan, SN
    Yang, M
    BLOOD, 2000, 96 (11) : 120B - 120B
  • [8] INITIATION OF HUMAN CYTOMEGALOVIRUS-INFECTION REQUIRES INITIAL INTERACTION WITH CELL-SURFACE HEPARAN-SULFATE
    COMPTON, T
    NOWLIN, DM
    COOPER, NR
    VIROLOGY, 1993, 193 (02) : 834 - 841
  • [9] Discovery of a potent lethal factor inhibitor as an adjunct therapy of anthrax infection.
    Xiong, YS
    Shoop, WL
    Wiltsie, J
    Woods, A
    Guo, J
    Pivnichny, JV
    Felcetto, T
    Michael, BF
    Bansal, A
    Cummings, RT
    Cunningham, BR
    Friedlander, AM
    Douglas, CM
    Patel, SB
    Scapin, G
    Salowe, S
    Zaller, DM
    Chapman, KT
    Scolnick, EM
    Schmalz, DM
    Bartizal, K
    Hermes, JD
    MacCoss, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U967 - U967
  • [10] MHC PROTEINS AND HEPARAN-SULFATE PROTEOGLYCANS REGULATE MURINE CYTOMEGALOVIRUS-INFECTION
    PRICE, P
    ALLCOCK, RJN
    COOMBE, DR
    SHELLAM, GR
    MCCLUSKEY, J
    IMMUNOLOGY AND CELL BIOLOGY, 1995, 73 (04): : 308 - 315
12345